Modeling of Molecular Interaction between Apoptin, BCR-Abl and CrkL - An Alternative Approach to Conventional Rational Drug Design

• Soumya Panigrahi,

  Affiliation Department of Molecular Cardiology, Lerner Research Institute/NB-50, Cleveland, Ohio, United States of America

  ⨯
• Jörg Stetefeld,

  Affiliation Department of Chemistry, University of Manitoba, Winnipeg, Canada

  ⨯
• Jaganmohan R. Jangamreddy,

  Affiliation Department of Clinical and Experimental Medicine (IKE) and Integrative Regenerative Medicine Center (IGEN), Linköping University, Linköping, Sweden

  ⨯
• Soma Mandal,

  Affiliation Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada

  ⨯
• Sanat K. Mandal,

  Affiliations Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada, College of the North Atlantic, Clarenville, Newfoundland, Canada

  ⨯
• Marek Los

  * E-mail: marek.los@liu.se

  Affiliations BioApplications Enterprises, Winnipeg, Manitoba, Canada, Department of Clinical and Experimental Medicine (IKE) and Integrative Regenerative Medicine Center (IGEN), Linköping University, Linköping, Sweden

  ⨯